Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
174
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
04 Jul 2024 08:00
Voluntary Announcement - Hutchmed Announces Nda Acceptance In China For Tazemetostat For The Treatment Of Relapsed Or Refractory Follicular Lymphoma With Priority Review Status
Attachment
Exchange Announcement •
28 Jun 2024 18:32
Filing Of Form F-3
Attachment
Exchange Announcement •
28 Jun 2024 16:38
Blocklisting Six Monthly Return
Attachment
Exchange Announcement •
28 Jun 2024 16:36
Total Voting Rights
Attachment
Exchange Announcement •
26 Jun 2024 16:31
Date Of Board Meeting And Announcement Of 2024 Interim Results
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x